A synthetic biology approach to analyze evolution of programmed bacterial death
分析程序性细菌死亡进化的合成生物学方法
基本信息
- 批准号:9274315
- 负责人:
- 金额:$ 28.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AltruismAntibiotic TherapyAntibioticsApoptosisAutomationBacteriaBehaviorBiological ModelsBiological ProcessBiologyCessation of lifeDeath RateDevelopmentEngineeringEscherichia coliEvolutionFoundationsGenesGoalsGrowthInvestigationMaintenanceMeasurementMeasuresMediatingMicrofluidic MicrochipsMicrofluidicsModelingPopulationPopulation DynamicsProcessPublic HealthResearchSocial BehaviorStarvationStressStructureSurvivorsSynthetic GenesSystemTechniquesTechnologyTreatment ProtocolsVirulenceVisionWorkantimicrobialbaseclinically relevantdesigneffective therapyexperimental studyfitnessinnovationinsightmicrobialnovelnovel therapeuticspathogenpublic health relevanceresponsesynthetic biologytraittreatment strategy
项目摘要
DESCRIPTION (provided by applicant):
A synthetic biology approach to analyze evolution of programmed bacterial death Programmed death is commonly associated with a bacterial response to stressful conditions, such as starvation, presence of competitors, and antibiotic treatment. As death offers no benefit to its actor, evolution of programmed bacterial death is a fundamental, unresolved problem in biology. A popular explanation is that the death is "altruistic": it can provide direct or indirect benefitsto the survivors. In other words, death may represent the ultimate form of cooperation. By making this assumption, evolution of programmed death can be analyzed under the general framework of public-good cooperation. Using this framework, studies have suggested possible public goods resulting from death in various bacterial pathogens. However, there remains a fundamental gap in the definitive understanding of microbial social behavior in general and programmed bacterial death in particular. Indeed, advantage of altruistic death has never been unequivocally demonstrated in an experimental system. A major challenge in tackling this problem is the complexity of natural biological processes, where numerous confounding factors obscure interpretation and quantitative analysis of the benefits associated with death. For example, previous work has been criticized because gene manipulations involved led to multiple effects and so it is hard to tease apart different fitness consequences. These issues make the results open to alternative explanations, such as PCD representing a maladaptive response to stress. We propose to use a combination of synthetic-biology techniques and microfluidics to overcome these limitations. In particular, using a set of synthetic gene circuits in bacterium Escherichia coli to implement tunable altruistic death, we will quantitatively define the condition under which altruistic death can become advantageous at the population level and examine their evolutionary dynamics in the presence of cheating. To enable such analysis, we will develop a novel droplet-based platform to examine the evolutionary dynamics under different conditions. Building on such understanding, we will develop and evaluate new treatment strategies that will exploit the evolutionary dynamics. It is our vision that the proposed research
will have several broad impacts. First, it will fill the critical conceptual gap in our understandig of the evolution of programmed death. Second, it will generate novel insights into how bacteria respond to antibiotic-mediated stress, which has implications for designing novel therapeutic strategies against bacterial pathogens.
描述(由申请人提供):
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Collective antibiotic tolerance: mechanisms, dynamics and intervention.
- DOI:10.1038/nchembio.1754
- 发表时间:2015-03
- 期刊:
- 影响因子:14.8
- 作者:Meredith HR;Srimani JK;Lee AJ;Lopatkin AJ;You L
- 通讯作者:You L
A noisy linear map underlies oscillations in cell size and gene expression in bacteria.
- DOI:10.1038/nature14562
- 发表时间:2015-07-16
- 期刊:
- 影响因子:64.8
- 作者:Tanouchi Y;Pai A;Park H;Huang S;Stamatov R;Buchler NE;You L
- 通讯作者:You L
Dissecting the effects of antibiotics on horizontal gene transfer: Analysis suggests a critical role of selection dynamics.
- DOI:10.1002/bies.201600133
- 发表时间:2016-12
- 期刊:
- 影响因子:0
- 作者:Lopatkin AJ;Sysoeva TA;You L
- 通讯作者:You L
Coupling spatial segregation with synthetic circuits to control bacterial survival.
- DOI:10.15252/msb.20156567
- 发表时间:2016-02-29
- 期刊:
- 影响因子:9.9
- 作者:Huang S;Lee AJ;Tsoi R;Wu F;Zhang Y;Leong KW;You L
- 通讯作者:You L
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
通过膜破坏性和内体溶解螺旋多肽通过 CRISPR/Cas9 传递进行非病毒基因编辑
- DOI:10.1073/pnas.1712963115
- 发表时间:2018-05-08
- 期刊:
- 影响因子:11.1
- 作者:Wang HX;Song Z;Lao YH;Xu X;Gong J;Cheng D;Chakraborty S;Park JS;Li M;Huang D;Yin L;Cheng J;Leong KW
- 通讯作者:Leong KW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINGCHONG YOU其他文献
LINGCHONG YOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINGCHONG YOU', 18)}}的其他基金
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
使用工程干扰质粒靶向控制自传播质粒
- 批准号:
10434929 - 财政年份:2021
- 资助金额:
$ 28.89万 - 项目类别:
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
使用工程干扰质粒靶向控制自传播质粒
- 批准号:
10277518 - 财政年份:2021
- 资助金额:
$ 28.89万 - 项目类别:
Targeted control of self-transmissible plasmids by using engineered interfering plasmids
使用工程干扰质粒靶向控制自传播质粒
- 批准号:
10671458 - 财政年份:2021
- 资助金额:
$ 28.89万 - 项目类别:
Tradeoffs between fitness costs and transfer rates in horizontal gene transfer
水平基因转移中适应度成本和转移率之间的权衡
- 批准号:
10585969 - 财政年份:2017
- 资助金额:
$ 28.89万 - 项目类别:
Dynamics of horizontal gene transfer in response to antibiotic treatment
抗生素治疗反应中水平基因转移的动态
- 批准号:
9310629 - 财政年份:2017
- 资助金额:
$ 28.89万 - 项目类别:
Temporal E2F Dynamics and Cell-Fate Decisions in Single Mammalian Cells
单个哺乳动物细胞中的时间 E2F 动力学和细胞命运决策
- 批准号:
8631365 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
Temporal E2F Dynamics and Cell-Fate Decisions in Single Mammalian Cells
单个哺乳动物细胞中的时间 E2F 动力学和细胞命运决策
- 批准号:
9281550 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
A synthetic biology approach to analyze evolution of programmed bacterial death
分析程序性细菌死亡进化的合成生物学方法
- 批准号:
8673991 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
A synthetic biology approach to analyze evolution of programmed bacterial death
分析程序性细菌死亡进化的合成生物学方法
- 批准号:
8828720 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
Post-antibiotic effect and design of optimal antibiotic dosing protocols
抗生素后效应和最佳抗生素给药方案的设计
- 批准号:
9239349 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 28.89万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 28.89万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 28.89万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 28.89万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 28.89万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 28.89万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 28.89万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 28.89万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 28.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 28.89万 - 项目类别: